WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. PCG
2. BRVE
3. ATTO
4. EIX
5. OKE
6. SRE
7. CNS
8. LLY
9. GME
10. SLB

Go back to WELIREG® (belzutifan) Receives First European Commission Approval for Two Indications
Merck & Co. (NYSE: MRK) Delayed: 148.35 --0 (-0%)
Previous Close $148.35    52 Week High $65.46 
Open $148.35    52 Week Low $47.97 
Day High $148.35    P/E 100.92 
Day Low $148.35    EPS $1.47 
Volume 3,526